Literature DB >> 17035668

Measuring the reinforcing strength of abused drugs.

Jack Bergman1, Carol A Paronis.   

Abstract

Animal models for human diseases are highly valued for their utility in developing new therapies. Animals have long provided suitable platforms for the development of innovative surgical procedures and for the study of disease states that are relatively easy to produce in otherwise healthy animals, such as diabetes or hypertension. Increasingly, new strains of animals susceptible to common human illnesses are being introduced into medical research, promising new inroads into the treatment of a variety of organic disorders. Despite these advances in model development, psychiatric disorders, by and large, remain among the hardest to induce experimentally, and the search for reasonable animal procedures to study diseases of the mind is an ongoing challenge for experimental biologists. An exception to this limitation, however, comes in the study of drug abuse. Major developments in this area of research over the last several decades have steadily advanced our ability to identify pharmacological, genetic, and environmental determinants that contribute to the development of drug dependence and addictive behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035668     DOI: 10.1124/mi.6.5.9

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  13 in total

1.  Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.

Authors:  David R Maguire; Lisa R Gerak; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

2.  Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose.

Authors:  Mikhail N Koffarnus; James H Woods
Journal:  Addict Biol       Date:  2011-08-04       Impact factor: 4.280

3.  Quantification of drug choice with the generalized matching law in rhesus monkeys.

Authors:  Mikhail N Koffarnus; James H Woods
Journal:  J Exp Anal Behav       Date:  2008-03       Impact factor: 2.468

4.  Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule.

Authors:  Benjamin A Zimmer; Carson V Dobrin; David C S Roberts
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

5.  Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

Authors:  Anne Stößel; Regine Brox; Nirupam Purkayastha; Harald Hübner; Carsten Hocke; Olaf Prante; Peter Gmeiner
Journal:  Bioorg Med Chem       Date:  2017-04-29       Impact factor: 3.641

6.  Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.

Authors:  Sarah L Withey; Roger D Spealman; Jack Bergman; Carol A Paronis
Journal:  J Pharmacol Exp Ther       Date:  2019-08-14       Impact factor: 4.030

Review 7.  Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging.

Authors:  Michael A Nader; Matthew L Banks
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

Review 8.  Clinical models of decision making in addiction.

Authors:  Mikhail N Koffarnus; Brent A Kaplan
Journal:  Pharmacol Biochem Behav       Date:  2017-08-26       Impact factor: 3.533

9.  Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys.

Authors:  Matthew L Banks; Paul W Czoty; Jon E Sprague; Michael A Nader
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

Review 10.  Serotonergic mechanisms in addiction-related memories.

Authors:  Bríd A Nic Dhonnchadha; Kathryn A Cunningham
Journal:  Behav Brain Res       Date:  2008-07-01       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.